ArticleFrontiers in immunology2023

The immune checkpoint adenosine 2A receptor is associated with aggressive clinical outcomes and reflects an immunosuppressive tumor microenvironment in human breast cancer.

Basma Zohair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.